The Hidden Pathogenesis of CML: Is BCR-ABL1 the First Event?
Sign Up to like & getrecommendations! Published in 2019 at "Current Hematologic Malignancy Reports"
DOI: 10.1007/s11899-019-00549-1
Abstract: Identification of the BCR-ABL1 fusion oncogene in patients diagnosed with chronic myeloid leukemia (CML) led to the development of targeted therapy responsible for the dramatic survival benefits observed in the past two decades. However, despite… read more here.
Keywords: bcr; cml; hidden pathogenesis; event ... See more keywords